Skip to main content
. 2023 Sep 30;15(19):4822. doi: 10.3390/cancers15194822

Figure 1.

Figure 1

Flowchart of the patient selection process. From the initial cohort of 100 randomly selected patients, only those with non-small cell lung cancer (NSCLC) brain metastases (METS) who presented with at least one lesion with a longest diameter (LD) ≥10 mm were included in our study (T1c+: post-contrast T1-weighted).